NCT06076421 Equity Evaluation of Fact Boxes on Informed COVID-19 and Influenza Vaccination Decisions - Study Protocol Status RECRUITING Phase NA
NCT06070896 Advanced Modeling of the Evolution of the Epidemiological Outbreak of SARS-CoV-2 Pandemic Status COMPLETED Phase N/A
NCT06068569 Study of the Vector Vaccine GamCovidVac for the Prevention of COVID-19 With Altered Antigenic Profile With Participation of Adult Volunteers Status UNKNOWN Phase PHASE3
NCT06068556 Study of the Vector Vaccine GamCovidVac-M (Altered Antigenic Composition) Status UNKNOWN Phase PHASE3
NCT06065176 The Efficacy of the 2023-2024 Updated COVID-19 Vaccines Against COVID-19 Infection Status COMPLETED Phase PHASE4
NCT06063330 Clinical Trial to Evaluate the Safety of RQ-01 in SARS-CoV-2 Positive Subjects Status COMPLETED Phase PHASE1
NCT06057025 Study of "Sputnik Lite" for the Prevention of COVID-19 With Altered Antigenic Composition. Status UNKNOWN Phase PHASE3
NCT06052527 Covid-19, Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) and Influenza Treatment System With Machine Learning Status COMPLETED Phase N/A
NCT06050460 SA55 Injection: a Potential Therapy for the Prevention and Treatment of COVID-19 Status UNKNOWN Phase PHASE1
NCT06048393 SA55 Novel Coronavirus Broad-spectrum Neutralizing Antibody Nasal Spray in Health People Status UNKNOWN Phase PHASE1
NCT06044233 A Bioequivalence Trial of Fasting Single Oral STI-1558 Capsule in Healthy Chinese Subjects Status COMPLETED Phase PHASE1
NCT06043882 Number of Participants Diagnosed With Sarcoidosis by Bronchoscopic Transbronchial Needle Aspiration After COVID- 2019 . Status COMPLETED Phase N/A
NCT06042881 Retrospective Cohort Study of the Physiotherapy in Critically Ill Covid Patients Status UNKNOWN Phase N/A
NCT06039449 A Study to Investigate the Prevention of COVID-19 WithVYD222 in Adults with Immune Compromise and in Participants Aged 12 Years or Older Who Are At Risk of Exposure to SARS-CoV-2 Status COMPLETED Phase PHASE3
NCT06039163 A Study to Assess the Safety, Tolerability and Preliminary Efficacy of HH-120 for the Treatment of COVID-19 Status COMPLETED Phase PHASE1